Akèy › Dematit atopik (Ekzema) › Massachusetts
Etid klinik pou Dematit atopik (Ekzema) nan Massachusetts
6 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan Massachusetts.
Vil nan Massachusetts
Tèks ofisyèl etid la (Anglè)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Brighton
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
- CorEvitas, LLC, Waltham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT04504955A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Boston Specialists /ID# 265810, Boston
- Beacon Clinical Research /ID# 263843, Quincy
Ap rekriteFaz 3
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- CorEvitas, LLC, Waltham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 10 a 15 · Tout sèks · Mizajou Jun 29, 2026 · NCT06238765Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
- Boston Children's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 6 a 65 · Tout sèks · Mizajou May 18, 2026 · NCT04455906Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7065, Brighton
- Galderma Investigationa Site 7104, Milford
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.